Assembly Biosciences (ASMB) Payables (2010 - 2026)

Assembly Biosciences' Payables history runs 17 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Payables rose 29.03% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (up 29.03% YoY), while the FY2025 annual figure was $1.2 million, up 100.17% from the prior year.
• Payables was $1.1 million for Q1 2026 at Assembly Biosciences, down from $1.2 million in the prior quarter.
• In the past five years, Payables ranged from a high of $2.5 million in Q4 2022 to a low of $461000.0 in Q4 2023.
• Historically, Payables has averaged $1.2 million across 5 years, with a median of $1.1 million in 2026.
• The sharpest annual moves came in 2023 and 2025: Payables sank 81.51% in 2023, then jumped 100.17% in 2025.
• A 5-year view of Payables shows it stood at $2.5 million in 2022, then sank by 81.51% to $461000.0 in 2023, then climbed by 26.9% to $585000.0 in 2024, then surged by 100.17% to $1.2 million in 2025, then retreated by 3.59% to $1.1 million in 2026.
• The last three Payables figures came in at $1.1 million (Q1 2026), $1.2 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.